NEW DELHI: Hyderabad-based Bharat Biotech submitted an application for an emergency use authorization for Covaxin on Monday, becoming the third company to seek such regulatory approval in India after Pfizer and Serum Institute of India (SII) . Covaxin is the first fully locally developed candidate vaccine against Covid-19 to be …
Read More »Covid-19 vaccine: Bharat Biotech will conduct phase 3 trials on 26,000 volunteers
HYDERABAD: Bharat Biotech, which is developing Covaxin, a candidate vaccine for Covid-19, said on Friday that it has successfully completed interim analysis of phase I and II trials and is initiating phase III trials in 26,000 participants. “After successfully completing the interim analysis of Covaxin Phase 1 and 2 clinical …
Read More »Coronavirus Vaccine Update: Third Virus Vaccine Hits Big Hurdle – Final Test in US World News
A handful of dozens of experimental Covid-19 vaccines in human trials have reached the last and biggest hurdle: seeking the necessary proof that they actually work, as a U.S. advisory panel suggested a way to ration Tuesday. limited first doses once a vaccine wins. approval. AstraZeneca announced Monday that its …
Read More »As Covid Cases Rise, Government Plans SOP for Festival Season | India News
NEW DELHI: Amid the growing number of Covid-19 cases across the country, the government is now concerned about the upcoming festival season. The issue was discussed at the Covid-19 ministers group meeting on Saturday and the Health Ministry is likely to issue separate notices soon. The Ministry of Health will …
Read More »